Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: The SWISSI II randomized controlled trial

JAMA

Volumn 297, Issue 18, 2007, Pages 1985-1991

  Erne, Paul ^a   Schoenenberger, Andreas W ^b,d   Burckhardt, Dieter ^c   Zuber, Michel ^a   Kiowski, Wolfgang ^e   Buser, Peter T ^c   Dubach, Paul ^f   Resink, Therese J ^c   Pfisterer, Matthias ^c  

^a Division of Cardiology Kantonsspital Luzern   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d UNIVERSITY OF BERN   (Switzerland)

^e KLINIK IM PARK   (Switzerland)

^f Kantonsspital St Gallen   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MOLSIDOMINE;

ADULT; ARTICLE; BICYCLE ERGOMETRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; SILENT MYOCARDIAL ISCHEMIA; SURVIVAL; TREATMENT OUTCOME;

EID: 34248348601     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.297.18.1985     Document Type: Article

References (24)

1. Tzivoni D, Gavish A, Zin D, et al. Prognostic significance of ischemic episodes in patients with previous myocardial infarction. Am J Cardiol. 1988;62:661-664.
2. De Lorenzo F, Saba N, Dancy M, Kakkar VV, Kadziola Z, Xiao HB. Induced ischemia detected by dobutamine stress echocardiography in coronary heart disease patients after myocardial re-vascularization: experience in a district general hospital. Int J Cardiol. 2002;83:119-124.
3. Breitenbücher A, Pfisterer M, Hoffmann A, Burckhardt D. Long-term follow-up of patients with silent ischemia during exercise radionuclide angiography. J Am Coll Cardiol. 1990;15:999-1003.
4. Kaul U, Dev V, Manchanda SC, Wasir HS. Silent myocardial ischemia after percutaneous transluminal coronary angioplasty and its prognostic significance. Clin Cardiol. 1991;14:563-566.
5. Pfisterer M, Rickenbacher P, Kiowski W, Muller-Brand J, Burkart F. Silent ischemia after percutaneous transluminal coronary angioplasty: incidence and prognostic significance. J Am Coll Cardiol. 1993;22:1446-1454.
6. Zellweger MJ, Weinbacher M, Zutter AW, et al. Long-term outcome of patients with silent versus symptomatic ischemia six months after percutaneous coronary intervention and stenting. J Am Coll Cardiol. 2003;42:33-40.
7. Cohn PF, Fox KM, Daly C. Silent myocardial ischemia. Circulation. 2003;108:1263-1277.
8. Conti CR. Silent cardiac ischemia. Curr Opin Cardiol. 2002;17:537-542.
9. Knatterud GL, Bourassa MG, Pepine CJ, et al. Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study. J Am Coll Cardiol. 1994;24:11-20.
10. Davies RF, Goldberg AD, Forman S, et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation. 1997;95:2037-2043.
11. Pepine CJ, Geller NL, Knatterud GL, et al. The Asymptomatic Cardiac Ischemia Pilot (ACIP) study: design of a randomized clinical trial, baseline data and implications for a long-term outcome trial. J Am Coll Cardiol. 1994;24:1-10.
12. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J. 2000;21:1502-1513.
13. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187-220.
14. Nademanee K, Intarachot V, Josephson MA, et al. Prognostic significance of silent myocardial ischemia in patients with unstable angina. J Am Coll Cardiol. 1987;10:1-9.
15. Kayden DS, Wackers FJ, Zaret BL. Silent left ventricular dysfunction during routine activity after thrombolytic therapy for acute myocardial infarction. J Am Coll Cardiol. 1990;15:1500-1507.
16. Leroy F, McFadden EP, Lablanche JM, Bauters C, Quandalle P, Bertrand ME. Prognostic significance of silent myocardial ischaemia during maximal exercise testing after a first acute myocardial infarction. Eur Heart J. 1993;14:1471-1475.
17. Vona M, Ignone G, Douard H, Scardi S, Comazzi F; SMISS Group. SMISS Group. Prognostic evaluation of silent ischemia during exercise in patient with recent infarction: Italian multicenter study [in French]. Arch Mal Coeur Vaiss. 2000;93:121-130.
18. Dargie HJ, Ford I, Fox KM; TIBET Study Group. Total Ischaemic Burden European Trial (TIBET): effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. Eur Heart J. 1996;17:104-112.
19. Forslund L, Hjemdahl P, Held C, Eriksson SV, Bjorkander I, Rehnqvist N. Prognostic implications of ambulatory myocardial ischemia and arrhythmias and relations to ischemia on exercise in chronic stable angina pectoris (the Angina Prognosis Study in Stockholm [APSIS]). Am J Cardiol. 1999;84:1151-1157.
20. Pepine CJ, Cohn PF, Deedwania PC, et al. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life: the Atenolol Silent Ischemia Study (ASIST). Circulation. 1994;90:762-768.
21. Von Arnim T. Prognostic significance of transient ischemic episodes: response to treatment shows improved prognosis: results of the Total Ischemic Burden Bisoprolol Study (TIBBs) follow-up. J Am Coll Cardiol. 1996;28:20-24.
22. Dakik HA, Kleiman NS, Farmer JA, et al. Intensive medical therapy versus coronary angioplasty for suppression of myocardial ischemia in survivors of acute myocardial infarction: a prospective, randomized pilot study. Circulation. 1998;98:2017-2023.
23. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1-14.
24. Hochman JS, Lamas GA, Buller CE, et al. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med. 2006;355:2395-2407.